Imperial Valley News Center
Philanthropist T. Denny Sanford Makes Largest Single Donation Ever to San Diego Zoo to Construct New Sanford Children's Zoo
San Diego, California - During an all-hands employee meeting at the San Diego Zoo Friday, philanthropist T. Denny Sanford announced that he is making a $30 million donation—the largest single gift the San Diego Zoo has ever received. This generous gift will go toward the estimated $69 million cost of constructing a brand-new, completely reimagined children’s zoo, to be named The Sanford Children’s Zoo.
Governor Brown Issues Executive Order to Continue Expediting Recovery Efforts in Communities Impacted by Southern California Wildfires and Mudslides
Sacramento, California - Governor Edmund G. Brown Jr. issued an executive order to further assist recovery efforts in Southern California related to the Thomas Fire and subsequent mudslides. The order helps ensure there’s the staffing and resources needed to continue to respond to the ongoing disaster and expedite debris removal.
Sacramento, California - Governor Edmund G. Brown Jr. today issued a proclamation declaring January 15, 2018 as Dr. Martin Luther King, Jr. Day in the State of California.
Sacramento, California - On behalf of all Californians, Governor Brown and First Lady Anne Gust Brown honor Staff Sgt. Eric C. Schenck, who bravely gave his life in service to our state and nation. The Governor and First Lady extend their deepest condolences to his family and friends at this difficult time.
Sacramento, California - CDFA Secretary Karen Ross welcomed stakeholders to the Eureka Room at the State Capitol for Thursday’s opening session of the Invasive Species Summit, a two-day event aimed at refining the state’ s approach and responsiveness to invasive species ranging from fruit flies and other insect pests to weeds, plant and animal diseases and other threats to our agriculture and the environment.
Washington, DC - The U.S. Food and Drug Administration Friday expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a “BRCA” gene mutation. Patients are selected for treatment with Lynparza based on an FDA-approved genetic test, called the BRACAnalysis CDx.
Page 1 of 2210